Dr Lal Pathlabs

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE600L01024
  • NSEID: LALPATHLAB
  • BSEID: 539524
INR
1,888.40
-6.7 (-0.35%)
BSENSE

Aug 04, 03:30 PM

BSE+NSE Vol: 5.39 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Thyrocare Tech.
Indegene
Dr Lal Pathlabs
Vijaya Diagnost.
Metropolis Healt
Vimta Labs
Nephrocare Healt
Krsnaa Diagnost.
Poly Medicure
Suven Life Scie.
Syngene Intl.

Why is Dr Lal Pathlabs Ltd ?

1
High Management Efficiency with a high ROE of 20.01%
2
The company is Net-Debt Free
3
Positive results in Jun 26
  • NET SALES(Q) Highest at Rs 797.70 cr
  • PBDIT(Q) Highest at Rs 247.50 cr.
  • OPERATING PROFIT TO NET SALES(Q) Highest at 31.03%
4
High Institutional Holdings at 38.96%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating performance in long term as well as near term
  • Along with generating 22.12% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Dr Lal Pathlabs should be less than 10%
  2. Overall Portfolio exposure to Healthcare Services should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Dr Lal Pathlabs for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Dr Lal Pathlabs
22.12%
0.73
30.13%
Sensex
-3.2%
-0.24
13.59%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.51%
EBIT Growth (5y)
5.97%
EBIT to Interest (avg)
18.65
Debt to EBITDA (avg)
0.44
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.08
Tax Ratio
23.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
38.96%
ROCE (avg)
53.14%
ROE (avg)
20.01%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
56
Industry P/E
66
Price to Book Value
12.50
EV to EBIT
45.36
EV to EBITDA
36.07
EV to Capital Employed
21.97
EV to Sales
10.45
PEG Ratio
5.63
Dividend Yield
1.02%
ROCE (Latest)
45.14%
ROE (Latest)
21.01%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET SALES(Q)

Highest at Rs 797.70 cr

PBDIT(Q)

Highest at Rs 247.50 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 31.03%

PBT LESS OI(Q)

At Rs 196.80 cr has Grown at 28.63%

PAT(Q)

Highest at Rs 169.50 cr.

EPS(Q)

Highest at Rs 10.11

-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 24.96 times

Loading Valuation Snapshot...

Here's what is working for Dr Lal Pathlabs

Net Sales - Quarterly
Highest at Rs 797.70 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 247.50 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 31.03%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 196.80 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 196.80 cr has Grown at 28.63%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 169.50 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 169.50 cr has Grown at 28.0%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 10.11
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Dr Lal Pathlabs

Debtors Turnover Ratio- Half Yearly
Lowest at 24.96 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly
Highest at Rs 31.90 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income